O&G · Antenatal care — maternal medical conditions
Obesity in pregnancy
Also known as Maternal obesity · Pregnancy in obesity · Class III obesity in pregnancy · Morbid obesity in pregnancy · BMI in pregnancy · Obesity complicating pregnancy
Exam-exhaustive FRANZCOG fellowship reference on maternal obesity in pregnancy — WHO BMI tiers and the rising risk ladder (GDM, preeclampsia, VTE, stillbirth, caesarean, congenital anomaly), gestational weight gain targets, anaesthetic referral triggers, weight-based enoxaparin dosing (Overcash, Stephenson), vitamin D per formulary, aspirin 150 mg (ASPRE) for preeclampsia prevention, intrapartum considerations, and the killer pitfalls. RANZCOG C-Obs 49 anchored, globally tagged to MRCOG and ABOG.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- BMI 40 or above — failed intubation is markedly more common; anaesthetic referral is mandatory, not optional
- Weight-based enoxaparin 0.5 mg/kg BID achieves prophylactic anti-Xa in 86% of obese post-caesarean women; fixed-dose 40 mg fails in 70%
- Fundal height lies above BMI 30 — customised growth charts and serial ultrasound replace the tape measure
- Vitamin D per local formulary daily from booking through lactation in BMI 30 and above
- Self-reported weight and height systematically underestimate BMI — measure both at booking
- Ergometrine, oestrogen-containing contraception and combined hormonal methods are VTE red flags above BMI 35
It is a Tuesday booking clinic. A 33-year-old G2P1 walks in at nine weeks. She is 168 cm tall and her scale weight reads 102 kg — BMI 36. She has been on combined oral contraceptive until last month, has polycystic ovary syndrome and her mother has type 2 diabetes. If you book her as routine antenatal care, you have missed every risk that the pregnancy carries. Obesity in pregnancy is the commonest modifiable risk factor on a labour ward, and almost every fellow-level question on this topic tests whether you have tiered the plan to the BMI.[1][4]
Overview and definition
Maternal obesity is BMI 30 or above calculated from a measured weight and height in early pregnancy. The deeper point is that obesity is not a single risk — it is a multiplier of every obstetric complication, and the multiplier scales with the BMI class.[1][2]
- WHO BMI tiers drive the tiered antenatal plan: overweight 25 to 29.9, class I obesity 30 to 34.9, class II 35 to 39.9, class III (morbid) 40 and above.[1][2]
- Three BMI thresholds, three actions — BMI 30 is the screening cut, BMI 35 is the anaesthetic-referral cut, BMI 40 is the MDT-and-bariatric-equipment cut. Memorise these as triggers, not trivia.
- Asian populations carry equivalent risk at lower BMI — the WHO Asian cutoffs (overweight at 23, obese at 25) are clinically relevant in ANZ.[1]
- Gestational weight gain in obese women is targeted at 5 to 9 kg (Institute of Medicine 2009, RANZCOG-aligned).[2]
Headline numbers for the obese pregnant woman
References17ShowHide
- [1]Denison FC, Aedla NR, Keag O, Hor K, Reynolds RM, Milne A, Diamond A; Royal College of Obstetricians and Gynaecologists Care of Women with Obesity in Pregnancy: Green-top Guideline No. 72 BJOG, 2019.PMID 30465332
- [2]American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 156: Obesity in Pregnancy Obstet Gynecol, 2015.PMID 26595582
- [3]Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, Curtis KM Maternal obesity and risk of stillbirth: a metaanalysis Am J Obstet Gynecol, 2007.PMID 17826400
- [4]Haken C, Fitzsimons K Obesity in pregnancy: addressing the issues at the booking appointment Pract Midwife, 2011.PMID 21473324
- [5]Overcash RT, Somers AT, LaCoursiere DY Enoxaparin dosing after cesarean delivery in morbidly obese women Obstet Gynecol, 2015.PMID 26000508
- [6]Stephenson ML, Serra AE, Neeper JM, Caballero DC, McNulty J A randomized controlled trial of differing doses of postcesarean enoxaparin thromboprophylaxis in obese women J Perinatol, 2016.PMID 26658126
- [7]Abdul Sultan A, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ Risk of first venous thromboembolism in pregnant women in hospital: population based cohort study from England BMJ, 2013.PMID 24201164
- [8]Sultan AA, West J, Grainge MJ, Riley RD, Tata LJ, Stephansson O Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study BMJ, 2016.PMID 27919934
- [9]De-Regil LM, Palacios C, Lombardo LK, Peña-Rosas JP Vitamin D supplementation for women during pregnancy Cochrane Database Syst Rev, 2016.PMID 26765344
- [10]Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S; American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Obesity (Silver Spring), 2013.PMID 23529939
- [11]Galazis N, Docheva N, Simillis C, Nicolaides KH Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis Eur J Obstet Gynecol Reprod Biol, 2014.PMID 25126981
- [12]Rottenstreich A, Elazary R, Goldenshluger A, Pikarsky AJ, Elchalal U, Ben-Porat T Maternal nutritional status and related pregnancy outcomes following bariatric surgery: A systematic review Surg Obes Relat Dis, 2019.PMID 30658948
- [13]Mahawar KK, Graham Y, Small PK Optimum time for pregnancy after bariatric surgery Surg Obes Relat Dis, 2016.PMID 27350179
- [14]Rottenstreich A, Shufanieh J, Kleinstern G, Goldenshluger A, Elchalal U, Elazary R The long-term effect of pregnancy on weight loss after sleeve gastrectomy Surg Obes Relat Dis, 2018.PMID 30166263
- [15]Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY Endocr Pract, 2019.PMID 31682518
- [16]Goldenshluger A, Elazary R, Ben Porat T, Farhat HG, Levin G, Rottenstreich A Knowledge, attitudes, and behaviors of women during pregnancy after bariatric surgery Surg Obes Relat Dis, 2020.PMID 32317215
- [17]Rolnik DL, Wright D, Poon LC, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med, 2017.PMID 28657417